Bio Impact Capital LLC Viridian Therapeutics, Inc.\De Transaction History

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.09 - $23.82 $8.78 Million - $12.2 Million
514,010 Added 514.01%
614,010 $10.8 Million
Q4 2023

Feb 13, 2024
SELL
$11.12 - $22.5 $1.73 Million - $3.49 Million
-155,323 Reduced 60.83%
100,000 $2.18 Million
Q2 2023

Aug 14, 2023
BUY
$22.57 - $29.67 $5.76 Million - $7.58 Million
255,323 New
255,323 $6.07 Million

Others Institutions Holding VRDN

# of Institutions
179
Shares Held
76.8M
Call Options Held
581K
Put Options Held
439K
View Full List

About Viridian Therapeutics, Inc.\DE

VRDN Quotes by TradingView
  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $806M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email